Once the new financial results are released the numbers should look much better as they will be a cleaner representation of the company going on and it won't look so disastrous on screening metrics with the impairment which masked the fiscal improvement. Clearly needs some other catalyst to get people to bid up though and with the volatility of the market could get cheaper from here still, but its 4 years of horizontalish movement so any breakout has the potential to be big but has failed to break resistance with multiple announcements in the last year, so clearly there isn't enough FOMO
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
Once the new financial results are released the numbers should...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
-0.010(4.55%) |
Mkt cap ! $48.10M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $87.21K | 406.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 400685 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 23537 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 400685 | 0.210 |
5 | 113536 | 0.205 |
14 | 180879 | 0.200 |
1 | 5000 | 0.195 |
1 | 27027 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 23537 | 2 |
0.225 | 50000 | 1 |
0.230 | 50000 | 1 |
0.235 | 117350 | 1 |
0.250 | 200000 | 3 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online